Episode Details

Back to Episodes
Nick Norwitz Has Total Cholesterol of 700 β€” So Why Zero Plaque? – TFP #030 | Nick Norwitz MD PhD

Nick Norwitz Has Total Cholesterol of 700 β€” So Why Zero Plaque? – TFP #030 | Nick Norwitz MD PhD

Season 1 Episode 30 Published 1Β month, 4Β weeks ago
Description

In this episode of The Feldman Protocol, can living with an LDL of 700 for seven years actually leave your arteries plaque-free? Nick Norwitz (MD PhD) makes the case that the conventional cholesterol narrative is far more complicated than mainstream medicine admits, while Dave and Nick also cover the paternalistic medical system, statin side effects in women, Nick's surprising decision to take a cholesterol-lowering drug, and the recent Peter Attia rebuttal to lean mass hypersponder research.


---


πŸ”₯ This episode is sponsored by us --

Own Your Labs πŸ‘‰ `https://ownyourlabs.com/sp/30`

Private blood testing services

🩸Over 300 blood tests

πŸ’°Extremely affordable

❀️ We love our customers

(Yes, we are literally funding the entire podcast from our own company -- so if you want to show your support, keep getting your private blood testing through our service. Thank you! πŸ™)


---


πŸ”— CONNECT WITH DAVE FELDMAN:

Main Channel: `https://youtube.com/@realDaveFeldman`

X/Twitter: `https://x.com/realDaveFeldman`

Instagram: `https://instagram.com/realDaveFeldman`

Website: `https://thefeldmanprotocol.com`


---


⏱ Chapters

3:03 – Who is Nick Norwitz?

3:51 – Leaving medicine's conventional path

5:52 – The calling Dave never felt

8:23 – Science communication as medicine's future

10:30 – Empowering patients with information

11:24 – Statins lower GLP-1: the hidden data

13:10 – Death knell of paternalistic medicine

16:19 – Dave's origin: The Feldman Protocol

18:31 – Why "we don't know" comforts patients

21:43 – Nick's illness, misdiagnosis & obsession

24:04 – The podcast origin story & echo disaster

28:41 – Cholesterol Code film blowing up

31:19 – Balancing science and accessibility in film

36:06 – Peter Attia's rebuttal to LMHR research

38:18 – Who's willing to have an open conversation?

41:01 – Causality vs. importance in lipid science

44:17 – Over-medicating metabolically healthy people

47:01 – Statins harm women more: the X chromosome mechanism

50:45 – The nocebo effect as gaslighting

55:03 – Dave's blinded crossover statin experiment

57:04 – Plot twist: Nick is taking a cholesterol drug

59:05 – Ezetimibe and Alzheimer's disease

1:02:01 – Plot twist 2: why Nick chose ezetimibe

1:04:00 – Plot twist 3: the 7-year coronary CT angiography

1:08:19 – Nick's CAD score at year 2 & family risk

1:14:10 – Clinical experience vs. contending with data

1:23:33 – Is Nick anti-statin? Dave presses hard

1:27:34 – Bempedoic acid & PPAR alpha activation

1:32:39 – Peter Attia's article vs. the LMHR team

1:36:24 – How to find Nick Norwitz everywhere


---


#FeldmanProtocol #DaveFeldman #NickNorwitz #LDLCholesterol #LeanMassHypersponder #CholesterolCode #StatinSideEffects #Ezetimibe #HeartHealth #LipidResearch #MetabolicHealth #Atherosclerosis #PatientEmpowerment #ScienceCommunication #Bempedoicacid #AlzheimersResearch #CardiovascularHealth #LowCarb #KetogenicDiet


Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us